Financial News · Live Terminal

Page 1 of 532

GRAIL's Galleri Blood Test to Be Evaluated by US FDA Advisory Panel

GRAIL (GRAL) said Friday that an advisory panel of the US Food and Drug Administration will convene on Sept. 23 to evaluate the premarket approval application for its Galleri multi-cancer early detection blood test.The firm submitted the marketing application Jan. 29, incorporating trial results from 25,490 participants in its PATHFINDER 2 study along with over 70,000 subjects from its NHS-Galleri trial, the company said.Shares of the company were up about 8.9% in Friday trading.Price: $69.03, Change: $+5.63, Percent Change: +8.88%

$GRAL

Wire13m ago

Top Cryptocurrencies Rise; Bitcoin Holds Above $64,000

Major digital assets rose Friday with Bitcoin (BTC-USD) still holding above $64,000.The CoinDesk Market Index, which tracks dozens of digital assets including Bitcoin, rose 0.3% in the past 24 hours. The Nasdaq 100 added 1.3%, the S&P 500 gained 0.6%, and the Dow Jones Industrial Average increased 0.2%.Bitcoin gained 0.9% to $64,938, according to CoinMarketCap data. The most popular cryptocurrency's 24-hour trading volume rose almost 11% to $21.65 billion.Ethereum (ETH-USD), the second-largest digital asset by market value, rose 0.6% to $1,918.XRP (XRP-USD) fell 1.1%, BNB (BNB-USD) increased 0.5%, and Solana (SOL-USD) rose 1.5%. Dogecoin (DOGE-USD) added 1.6%, while Cardano (ADA-USD) dropped 0.8%.The total market value of the cryptocurrency industry rose 0.6% in the past 24 hours to $2.21 trillion, with trading volume rising 5.3% to $55.6 billion.Price: $64913.74, Change: $+654.06, Percent Change: +1.02%

$ADA-USD$BNB-USD$BTC-USD$DOGE-USD$ETH-USD$SOL-USD$XRP-USD

Wire28m ago

Celestica Completes $3.45 Billion Equity Offering

Celestica (CLS) said Friday it completed a $3.45 billion equity offering through the sale of about 11.1 million common shares priced at $310 each.The offering comprised roughly 9.7 million common shares, with the underwriters fully exercising their option to purchase an additional 1.5 million shares.Celestica said it expects to use the net proceeds for working capital, investments in capital expenditures and other general corporate purposes.Price: $317.60, Change: $+3.07, Percent Change: +0.98%

$CLS

Wire29m ago

Castor Maritime Forms JV With Third-Party Investors

Castor Maritime (CTRM) said Friday it entered an agreement to form a joint venture with third-party investors that will acquire and operate a Karmsarmax bulk carrier vessel owned by the company.The company contributed the vessel to the JV in exchange for a 30% equity interest and $18.8 million in cash, according to a statement.The deal is expected to result in a net gain of $2.9 million to the company during Q3, according to the company.Price: $2.01, Change: $-0.08, Percent Change: -3.83%

$CTRM

Wire34m ago

FirstEnergy Unit JCP&L Files for Proposed $253 Million Base Rate Increase

FirstEnergy (FE) said Friday its unit Jersey Central Power & Light filed a rate proposal with the New Jersey Board of Public Utilities seeking a $253 million increase in base distribution rates, which would raise bills by about 7% when proposed offsets expire in 2028.The filing also seeks recovery of $476 million in previously deferred storm costs through a separate charge effective January 2028, spread over 10 years, the company said.Price: $47.51, Change: $+0.60, Percent Change: +1.28%

$FE

Wire34m ago

Twin Disc Increases Dividend by $0.01 to $0.05 a Share, Payable Sept. 1 to Stockholders of Record Aug. 18

$TWIN

Wire43m ago

TORM Says Oaktree Capital No Longer Holds Stake as Brookfield Assumes Control

TORM (TRMD) said Oaktree Capital Group Holdings no longer indirectly holds any shares or voting rights in the company as of July 31, following a change in the ownership structure of OCM Njord Holdings.Brookfield (BN) has become the ultimate controlling shareholder of Njord as part of the transaction, TORM said Friday in a statement.Njord's direct stake in TORM remains unchanged at 20.4 million Class A shares, representing 19.86% of the total share capital and voting rights, TORM said.Price: $29.47, Change: $-0.02, Percent Change: -0.07%

$BN$TRMD

Wire46m ago

Viking Takes Delivery of River Ship, Expanding Nile Fleet

Viking (VIK) said Friday it took delivery of a ship in Egypt, which was purpose-built for the Nile River.The ship is expected to host 82 guests in 41 staterooms during Viking's 12-day Pharaohs & Pyramids itinerary, the company said.The company expects to take delivery of 20 more river ships by 2028, nine ocean ships by 2031, and two expedition ships by 2031, according to a statement.Price: $105.75, Change: $-0.44, Percent Change: -0.41%

$VIK

Wire49m ago

BitFuFu July Bitcoin Production Falls Sequentially

BitFuFu (FUFU) said Friday that it produced 112 bitcoins in July, compared with 125 bitcoins produced in the previous month.The company said it held 1,314 bitcoins in July, compared with 1,671 bitcoins in June, a decrease driven by advance payments made for future hashrate capacity scheduled to begin in August and extend for 330 days.

$FUFU

Wire50m ago

BTQ Technologies Completes First Milestone in Global QCIM Chip Roadmap

BTQ Technologies (BTQ) said Friday it has completed the first milestone of its multi-year collaboration with the Industrial Technology Research Institute to validate quantum compute-in-memory architecture for post-quantum cryptography.The program will now move to its next phase, focused on module-level integration, verification and validation, to further evaluate how the QCIM core can be integrated into system architectures, the company said.The company said it expects to ship test chips to key customers and strategic partners for performance and functional validation by year-end.Price: $4.08, Change: $+0.08, Percent Change: +1.88%

$BTQ

Wire56m ago

B2Gold Gets Fekola Regional Exploitation Permit From Mali, Shares Rise

B2Gold (BTG) has secured the Menankoto exploitation permit from the government of Mali, a key approval for the development of its Fekola Regional project, the gold producer said Friday.B2Gold will begin mining pre-stripping activities and finalize a tolling agreement for the project, according to a statement.Fekola Regional, which will be owned 65% by B2Gold and 35% by the State of Mali, is expected to ramp up operations through the end of 2027 and produce more than 150,000 ounces annually from 2028 through the mid-2030s. the company said.Shares rose more than 23% in Friday afternoon trading.Price: $5.06, Change: $+0.97, Percent Change: +23.69%

$BTG

Wire1h ago

Intel Names Dean Jarnac as Chief Sales Officer

Intel (INTC) said Friday it appointed Dean Jarnac as executive vice president and chief sales officer, effective in September.Jarnac joins Intel from Marvell Technology (MRVL), where he served as chief sales officer. He previously held senior sales leadership roles at Broadcom (AVGO) and Advanced Micro Devices (AMD).Greg Ernst will leave Intel after 27 years as part of the transition, Intel said.Price: $101.04, Change: $+1.23, Percent Change: +1.24%

$INTC

Wire1h ago

NRX Pharmaceuticals to Submit Attestation to FDA on Packaging Deficiency for Ketamine Product

NRX Pharmaceuticals (NRXP) said Friday it plans to provide manufacturing attestation requested by the US Food and Drug Administration related to packaging for approval of its preservative-free ketamine's Abbreviated New Drug Application.The agency has completed first-cycle review and found no major deficiencies related to the drug product, ingredients, proposed labeling, Chemistry, Manufacturing and Controls, or other drug-related review matters, NRX said.Meanwhile, the agency found a major deficiency related to packaging in the first-cycle review of the drug, NRX said. The deficiency is related to evidence that the luer lock tip of the medication vial would perform properly when connected to a syringe by a licensed health professional, the company said.NRX said it plans to provide manufacturing attestation requested by the agency that the product is manufactured on the same manufacturing lines with the same methods as three currently approved products.Price: $3.59, Change: $+0.50, Percent Change: +16.18%

$NRXP

Wire1h ago

General Dynamics Unit Wins $1.3 Billion Army National Guard IT, Cybersecurity Contract

General Dynamics (GD) unit GDIT was awarded a $1.3 billion contract to provide enterprise IT and cybersecurity services for the US Army National Guard and other federal government partners, the company said Friday.The Enterprise Network Operations and Cybersecurity Support contract, awarded by the General Services Administration's Assisted Acquisition Services, has a one-year base period and six one-year option periods, the company said.GDIT will operate, modernize, integrate and defend the Guard's classified and unclassified networks, the company said.The company said it will also provide integrated IT services, including establishing new operations centers, workforce support and technology provisioning, while deploying artificial intelligence, data analytics and communication capabilities to enhance mission execution.Price: $389.56, Change: $+2.64, Percent Change: +0.68%

$GD

Wire1h ago

Pulse Biosciences Shares Rise After Q2 Results

Pulse Biosciences (PLSE) shares were up 6.6% in Friday trading, a day after the company reported its Q2 results.The company posted a Q2 net loss of $0.36 per diluted share, widening from a loss of $0.28 a year earlier.Three analysts polled by FactSet expected a $0.36 loss.Revenue for the quarter ended June 30 was $434,000.Three analysts expected $500,000.Pulse Biosciences said cash and cash equivalents totaled $101.6 million as of June 30.Price: $40.76, Change: $+2.52, Percent Change: +6.58%

$PLSE

Wire1h ago

FIGS Shares Rise After Q2 Earnings, Revenue Increase

FIGS (FIGS) shares rose 28% in Friday trading after it reported Q2 earnings late Thursday of $0.15 per diluted share, up from $0.04 a year earlier.Analysts polled by FactSet expected $0.07.Net revenue for the quarter ended June 30 was $196.6 million, up from $152.6 million a year earlier.Analysts polled by FactSet expected $186.2 million.Price: $14.37, Change: $+3.13, Percent Change: +27.85%

$FIGS

Wire1h ago

Tango Therapeutics Executive Chair Barbara Weber Departs

Tango Therapeutics (TNGX) executive chairman Barbara Weber has decided to step down from the role, the company said late Thursday.Weber's employment with the company as its executive chair ended on Aug. 3, the company said in a regulatory filing, adding that the resignation was not a result of any disagreement on any matter relating to the company's operations, practices or policies.Shares were down nearly 6% in Friday afternoon trading.Price: $27.22, Change: $-1.78, Percent Change: -6.14%

$TNGX

Wire1h ago

Tandem Diabetes Care's Underlying Q2 Trends Better Than Headline Suggests, RBC Says

Tandem Diabetes Care (TNDM) delivered a stronger underlying Q2 than the headline results suggested, with improving execution and faster-than-expected adoption of its PayGo subscription model, RBC Capital Markets said.The company's PayGo subscription model is gaining significant traction in its first full quarter, with 10% of US sales coming through pharmacy channels. Formulary coverage has reached 45%, already approaching the high end of Tandem's full-year target, according to the note Thursday.The near-term headwind from zero-upfront PayGo pump shipments was about $8 million in Q2, but was more than offset by favorable supply pricing. RBC called PayGo a "transformational shift" that more than doubles expected lifetime revenue per patient while removing the largest barrier to pump adoption.The investment firm also said underlying US pump demand remains healthy, with record second-quarter shipments of 22,000 pumps, sequential growth of more than 20% in new starts and continued strength in multiple daily injection conversions.Tandem submitted an application for its Mobi Tubeless insulin delivery system, with management targeting clearance and a scaled launch in H2. If launched on schedule, 2027 would be the first full year of contribution from the product, which RBC expects to drive meaningful revenue acceleration and margin expansion.RBC maintained the company's stock rating at outperform and adjusted the price target to $26 from $30.Shares of Tandem Diabetes were up more than 17% in Friday trading.Price: $22.07, Change: $+3.28, Percent Change: +17.46%

$TNDM

Wire1h ago

BlossomHill Therapeutics Shares Fall in Nasdaq Debut

BlossomHill Therapeutics (BLSM) shares fell 2.3% to $15.63 in their Nasdaq debut on Friday.The stock opened at $15.75 and reached $16 before trading as low as $15.25.The company priced its upsized initial public offering of 9.375 million common shares at $16 each, raising $150 million in gross proceeds.The underwriters were granted a 30-day option to buy up to an additional 1.4 million shares.The offering is expected to close Monday.Price: $15.63, Change: $-0.37, Percent Change: -2.31%

$BLSM

Wire1h ago

Datadog's AI Cohort Continues to Grow Rapidly, Oppenheimer Says

Datadog's (DDOG) artificial intelligence cohort continues to grow rapidly and is diversifying, including 750 and more AI-native customers, all 10 of the largest AI companies, with eight spending $10 million and more annually, Oppenheimer said in a Thursday research note.Oppenheimer said that the company's guidance for the full year appears to be fully derisked after its largest customer OpenAI renewed in Q3 with lower usage expected, allowing better clarity on the overall business performance.The brokerage also said that the difference between the company's raised guidance for 2026 and investor expectations reflects the company's measured approach.Oppenheimer maintained the company's outperform rating with a $300 price target.Price: $235.35, Change: $+6.06, Percent Change: +2.64%

$DDOG

Showing 1-20 of 10633